Summer School 2023

Summer School: Digital Mobility Outcomes for Health Promotion and Prevention: Extracting actionable insights from real-world data  30th of July – 4th of August 2023, Bishop’s Fortress of Bertinoro, Italy  The Mobilise-D consortium and the Italian DARE Initiative are delighted to invite PhD students, early career researchers, health practitioners, patient organisations, technology developers, pharmaceutical representatives, and other interested professionals to…

Mobilise-D and C-Path announce collaboration agreement

The Mobilise-D consortium and the Critical Path Institute (C-Path) are thrilled to announce the signing of a collaboration agreement, which will be an important step forward in achieving lasting impact. C-Path is an independent nonprofit, public-private partnership with the U.S. Food and Drug Administration (FDA). C-Path orchestrates the development of actionable solutions through an innovative, collaborative…

Mobilise-D and Cure Parkinson’s UK in strategic partnership to accelerate the translation of research into clinical practice

We are excited to announce our strategic partnership with Cure Parkinson’s UK, working closely together to bring our research and clinical studies closer to patients and the public. We asked Helen Matthews, Deputy CEO of Cure Parkinson’s, to share with us her vision about the benefits of the research and clinical trials in Parkinson’s Disease,…

A new Mobilise-D scoping review: The clinical utility of digital mobility outcomes

Walking has the potential to be a rich indicator of health in many medical conditions. In recent years, scientific research has proposed more than 100 digital mobility outcomes (DMOs) that could be used to assess walking, and thereby monitor health status, using digital technologies. Though they show great promise, these DMOs require further validation.  Researchers must…

Novartis job opportunity for analysis of wearable sensor data for Digital Mobility Outcomes

Novartis is now looking for a Digital Data Scientist to join their group and participate in their ground-breaking medical research activities that redefine the grammar for medicine in the post-genome era. The Digital Data Scientist in Novartis will understand complex and critical business problems, formulate integrated analytical approach to mine data sources, employ statistical methods…

Key challenges in the use & development of digital endpoints from a health technology assessment (HTA) perspective

Digital endpoints offer a great potential to be considered in the HTA framework. So far, however, there is no institutional way in.  On February 15, 2021, IMI Neuronet hosted an online meeting of its working group on health technology assessment (HTA) and regulatory interactions, moderated by Diana O’Rourke from the National Institute for Health and Care Excellence (NICE). The discussions were based around the experiences of three different IMI projects that are…

IMI article about our Digital Health Catalyst initiative

The Digital Health Catalyst (DHC) was created by Mobilise-D and IDEA-FAST in response to the growing need for research and application in the area of real-world digital measurements. “The field will require a new generation of personnel from areas including clinical research and application, sensor and hardware development, infrastructure and data handling, data processing and…